Travere Therapeutics reported third-quarter 2025 earnings, highlighting revenue of US$164.86 million and net income of US$25.71 million, a sharp turnaround from the net loss a year earlier, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback